Posted on 11/8/16
Concert Pharmaceuticals Reports Third Quarter 2016 Financial Results
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2016.“As we approach the end of the year, our team . . .
Posted on 11/8/16
Karyopharm Therapeutics' (KPTI) CEO Michael Kauffman on Q3 2016 Results - Earnings Call Transcript
Karyopharm Therapeutics Inc. (NASDAQ:KPTI)Q3 2016 Earnings Conference CallNovember 7, 2016 5:00 PM ETExecutivesJustin Renz – Executive Vice President, Chief Financial Officer and TreasurerMichael Kauffman – Chief . . .
Posted on 11/8/16
3 Things You Really Need to Know About Arena Pharmaceuticals, Inc. Q3 Results
Like many biotechs, Arena Pharmaceuticals, Inc. (NASDAQ:ARIA) hasn't had a great year in 2016, so far. Shares of the biopharmaceutical company are down more than 20% . . .
Posted on 11/8/16
Editas Medicine Announces Third Quarter 2016 Results and Update
CAMBRIDGE, Mass., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today reported financial results for the third quarter ended . . .
Posted on 11/8/16
Takeda and Koneksa Health Announce Strategic Collaboration
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of . . .
Posted on 11/8/16
PixarBio Corp. Closed Placement Offering Totaling $23.4MM Plus a $10MM Line of Credit
CAMBRIDGE, Mass.--(BUSINESS WIRE)--PixarBio Corporation, (OTC:PXRB) inventors of NeuroRelease™, a novel morphine replacement, non-opiate/opioid, non-addictive pain treatment, today announced that it has completed the closing of the . . .
Posted on 11/8/16
Xenetic Biosciences Closes $10M Public Offering
LEXINGTON, Mass.--(BUSINESS WIRE)--Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a clinical-stage biopharmaceutical company focused on discovery, research and development of next-generation biologic drugs and novel . . .
Posted on 11/7/16
Proteon Therapeutics Announces Third Quarter 2016 Financial Results
WALTHAM, Mass., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with . . .
Posted on 11/7/16
Momenta Pharmaceuticals, Inc. Continues Its Wait for Higher Sales
IMAGE SOURCE: GETTY IMAGES.Momenta Pharmaceuticals (NASDAQ:MNTA) released third-quarter earnings on Wednesday. The drug company is producing solid sales for what it has to work with, but . . .
Posted on 11/7/16
Alnylam Pharmaceuticals, Inc. Discloses Deaths, Waits for More Data
IMAGE SOURCE: GETTY IMAGES.Alnylam Pharmaceuticals (NASDAQ:ALNY) fell 12.6% on Thursday after reporting earnings Wednesday afternoon, but it's recovered some of that today.Of course, it wasn't the . . .
Posted on 11/7/16
Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice
Boston Scientific Corporation (NYSE: BSX) today announced that its wholly owned merger subsidiary, Falcon Merger Corp., has extended its previously announced tender offer for all shares . . .
Posted on 11/7/16
Pulmatrix Reports Third Quarter 2016 Financial Results and Business Update
Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced it third quarter financial results and . . .
Posted on 11/7/16
Recovery Centers of America Opens First Drug and Alcohol Rehabilitation Center in Massachusetts
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Today,Recovery Centers of America (RCA)opens its newest drug and alcohol rehabilitation facility in Westminster, which will accept most major insurance plans, and . . .
Posted on 11/7/16
PAVmed Partners with Leading Academic Institutions
NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has signed a definitive licensing agreement with a . . .
Posted on 11/7/16
InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the quarter ended September 30, 2016.Mark Perrin, InVivo’s Chief Executive Officer and Chairman, said, . . .
Posted on 11/4/16
Pressure BioSciences Closes $2,000,000 Line-of-Credit
Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling constant pressure and pressure cycling technology-based sample preparation solutions to the . . .
Posted on 11/4/16
iSpecimen and Great Lakes Health Connect Announce Collaboration to Drive Medical Research
iSpecimen®, a trusted source of customized human biospecimen collections, today announced an agreement with Great Lakes Health Connect (GLHC), Michigan'sleading health information exchange (HIE). This agreement . . .
Posted on 11/4/16
InVivo Therapeutics Announces Allegheny General Hospital as New Site for INSPIRE Study
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that Allegheny General Hospital (AGH) in Pittsburgh, PA, part of Allegheny Health Network, has been added as . . .
Posted on 11/3/16
Interleukin Genetics Launches The ILUSTRAÔ Inflammation Management Program
Easy-to-deploy benefit enhancement can deliver significant health and economic value by targeting chronic inflammationInterleukin Genetics, Inc. (OTCQB:ILIU) a life science company focused on the genetics of chronic . . .
Posted on 11/3/16
Curis Reports Third Quarter 2016 Financial Results
LEXINGTON, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates . . .
Posted on 11/3/16
Minerva Neurosciences Reports Third Quarter 2016 Financial Results and Business Updates
WALTHAM, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous . . .
Posted on 11/3/16
Alliance HealthCare Services Announces Partnership with Signature Healthcare
BROCKTON, Mass.--(BUSINESS WIRE)--Alliance HealthCare Radiology (Alliance Radiology), a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), announced today a partnership with Signature Healthcare to offer expanded MRI, . . .
Posted on 11/2/16
Momenta Pharmaceuticals Reports Third Quarter 2016 Financial Results
CAMBRIDGE, Mass., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the third quarter ended September 30, 2016.For the . . .
Posted on 11/2/16
ProEx Physical Therapy Appoints Mollie Sanregret as Coop/Exercise Technician
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces that
Posted on 11/2/16
ImmunoGen, Inc. Waits for Data
IMAGE SOURCE: GETTY IMAGES.ImmunoGen (NASDAQ:IMGN) reported earnings on Friday, but except for its cash runway, the biotech's financials aren't nearly as important as plans for its . . .
Boston
